Friedenthal Financial Buys Shares of 300 The Clorox Company (NYSE:CLX)

Friedenthal Financial acquired a new position in The Clorox Company (NYSE:CLX) in the third quarter, Holdings Channel.com reports. The institutional investor acquired 300 shares of the company’s stock, valued at approximately $49,000.

Other large investors have also recently added to or reduced their stakes in the company. SG Americas Securities LLC increased its holdings in shares of Clorox by 1,525.7% during the first quarter. SG Americas Securities LLC now owns 65,612 shares of the company’s stock valued at $10,046,000 after purchasing an additional 61,576 shares during the period. Mizuho Markets Americas LLC boosted its stake in Clorox by 93.7% during the 1st quarter. Mizuho Markets Americas LLC now owns 72,053 shares of the company’s stock valued at $11,032,000 after purchasing an additional 34,864 shares in the last quarter. CANADA LIFE ASSURANCE Co boosted its stake in Clorox by 15.2% during the first quarter. CANADA LIFE ASSURANCE Co now owns 141,622 shares of the company’s stock valued at $21,705,000 after buying an additional 18,687 shares in the last quarter. Advisors Asset Management Inc. grew its holdings in Clorox by 257.5% during the first quarter. Advisors Asset Management Inc. now owns 11,228 shares of the company’s stock worth $1,719,000 after acquiring an additional 8,087 shares during the period. Finally, Game Plan Financial Advisors LLC bought a new stake in Clorox in the first quarter worth about $1,025,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Down 0.4 %

Shares of CLX opened at $161.96 on Friday. The Clorox Company has a 52 week low of $114.68 and a 52 week high of $169.09. The firm has a market capitalization of $20.11 billion, a P/E ratio of 83.92, a P/E/G ratio of 3.19 and a beta of 0.41. The company has a 50-day simple moving average of $159.28 and a 200-day simple moving average of $145.15. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.28. The company had revenue of $1.90 billion for the quarter, compared to analyst estimates of $1.97 billion. Clorox had a return on equity of 281.12% and a net margin of 3.95%. On average, equities research analysts expect that The Clorox Company will post 6.64 earnings per share for the current year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be paid a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.01%. Clorox’s dividend payout ratio is currently 252.85%.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on CLX shares. Wells Fargo & Company lowered their price objective on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a research note on Wednesday, July 10th. Evercore ISI cut their price objective on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. DA Davidson reiterated a “neutral” rating and issued a $153.00 price target on shares of Clorox in a research report on Friday, September 6th. Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. Finally, Barclays raised their target price on shares of Clorox from $130.00 to $137.00 and gave the stock an “underweight” rating in a report on Friday, October 11th. Six investment analysts have rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $150.14.

Insider Transactions at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.51% of the stock is currently owned by insiders.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.